
Menopause hormone therapy and osteoporosis are closely linked because bone loss accelerates at the end of perimenopause and the beginning of post-menopause, when oestrogen levels drop rapidly. This hormonal decline increases the risk of osteopenia, osteoporosis, and fractures later in life.
This article explains:

Bone is a living tissue, constantly being broken down and rebuilt.
Oestrogen plays a key role by slowing bone breakdown and supporting bone formation.
When oestrogen levels fall rapidly during the menopause transition:
The most rapid bone loss occurs in a narrow window around menopause, when oestrogen levels fall sharply.
Yes. Menopause hormone therapy helps prevent osteoporosis by:
Menopausal hormone therapy is approved and effective for osteoporosis prevention when started around menopause.

Menopause hormone therapy and osteoporosis prevention are most effective when treatment is:
Starting earlier protects bone during the period of fastest bone loss.
Benefits are clearly stronger when therapy begins early rather than late.
This does not reduce its value — it clarifies when and how it is best used.
Menopausal hormone therapy can help prevent osteoporosis when started early and used appropriately. As oestrogen levels decline rapidly around menopause, bone breakdown accelerates. Replacing oestrogen at the right time helps preserve bone strength, reducing fracture risk later in life.
Understand the best options for you
They support bone health, but osteoporosis is primarily caused by oestrogen loss, so combining these measures with the right medical strategy offers the best protection.
No. Menopause hormone therapy prevents bone loss, but established osteoporosis requires other treatments.
Menopause hormone therapy is most beneficial for bone health when started early, at the time estrogen levels decline sharply
BMS consensus statement. 2023. Prevention and treatment of osteoporosis.
Royal Osteoporosis Society. Hormone Replacement Therapy (HRT), 2025.